Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 100% —
Register , to see more distinctive signs of diseases and studies — 100%
secondary cataract
70%
—
rupture of the eyeball —
73%
glaucoma and cataracts
68%
—
sickle cell anemia —
56%
secondary glaucoma
66%
—
photophobia —
53%
pupils enlarged
58%
—
weak hazy vision —
52%
cataract
54%
—
hemoglobinopathies —
52%
dislocation of the lens
50%
—
spasm of accommodation —
47%
pupils are narrowed
48%
—
pain in the eyes —
47%
blunt trauma to the eye
47%
—
hemorrhagic purpura —
45%
corneal injuries
44%
—
rubeosis of iris —
45%
synechiae of pupil
44%
—
vascular damage —
44%
neovascular glaucoma
42%
—
choroid melanoma —
44%
aphakia
41%
—
melanoma of the eye —
44%
post - thrombophlebitic syndrome
41%
—
bruise —
43%
foreign body of the cornea
41%
—
bruises on the body —
41%
acute violation of ophthalmotonus
40%
—
violation of accommodation —
41%
intraocular pressure is lowered
40%
—
subconjunctival hemorrhage —
41%
aniridia
40%
—
blurred vision —
40%
keratoglobus
39%
—
chronic leukemia —
39%
fundus veins hemorrhages
37%
—
hemophilia —
38%
dislocation
36%
—
hemorrhage in the eye
27%
64%
pigmented glaucoma
36%
—
thrombocytopenic purpura —
36%
microphthalmos
35%
—
chronic inflammation of the eyes —
36%
vitreous detachment
34%
—
melanoma —
36%
fundus arteries narrowed
34%
—
acute leukemia —
36%
hemophthalmos
33%
—
flies in front of the eyes —
36%
corneal edema
33%
—
diabetes mellitus —
35%
acute vascular occlusion of the extremities
32%
—
anemia —
35%
scotoma
32%
—
autoimmune thrombocytopenia —
35%
swelling after injury
31%
—
conducting an inspection —
34%
eye development abnormalities
30%
—
headaches —
34%
scarring
30%
—
bleeding —
33%
retinal
30%
—
headache behind the eyes —
33%
loss of visual fields
30%
—
pain after injury —
33%
consequences of eye surgery
30%
—
need for protection —
33%
narrowing of the fields of vision
30%
—
primary immunodeficiency —
32%
corneal opacity
29%
—
leukemia —
31%
retinal dystrophy
29%
—
skin overgrowth —
31%
consequence of hormone treatment
29%
—
headache with dizziness —
30%
rough skin
29%
—
blood diseases
19%
49%
uveit
27%
—
vasculitis —
30%
peripheral artery thrombosis
26%
—
lowered —
29%
eye swelling
26%
—
chronic anemia —
29%
angiopathy of the retina
26%
—
neurological pain —
29%
feeling of fullness
25%
—
cancer in the anamnesis —
29%
sedentary lifestyle
25%
—
arterial bleeding —
29%
effects of taking hormones
25%
—
hemorrhages on the skin —
29%
wound postoperative
25%
—
increased motor activity —
28%
worse at 7 am
25%
—
fistula —
28%
veins bloating
24%
—
shroud
28%
56%
arterial occlusion
23%
—
blindness —
28%
general swelling does
23%
—
motor activity —
28%
dystrophy
22%
—
metastases —
27%
a history of organ transplantation
22%
—
thrombocytopenia —
27%
worse in morning
22%
—
traumatic illness —
26%
changes in the blood
21%
—
dizziness —
26%
hypotension
21%
—
increased bleeding —
26%
up circulatory disorders
20%
—
hemorrhagic diathesis —
26%
swelling
19%
—
immunodeficiency —
25%
angioplasty
19%
—
vascular tumor —
25%
consequences of eye injury
54%
36%
spasm —
25%
consequences of injuries
44%
35%
attacks of pain —
24%
eye surgery
49%
41%
hypertension —
24%
occlusion of the central retinal vein
45%
38%
drug disease —
22%
acute venous thrombosis
35%
29%
cancer
20%
41%
angiopathy
28%
23%
has a swelling of the eye
33%
54%
impaired venous function
29%
24%
s eyes cloudy
34%
49%
wound
20%
34%
visual impairment
22%
36%
consequences of surgery
19%
32%
oncology
18%
30%
history of surgery
37%
46%
trauma
40%
49%
thrombosis of the central retinal vein
47%
55%
mechanical damage to the eyes
47%
55%
eye injury
47%
55%
contusions of the eye
39%
46%
penetrating eye injury
36%
43%
consequences of taking medications
31%
37%
a foreign body in the eye
35%
41%
inflammation of the eyes
35%
41%
the consequences of bruise
30%
35%
inflammation
25%
30%
bruise
26%
31%
impaired arterial function
27%
32%
chorioretinitis
29%
34%
thrombosis
30%
35%
venous congestion
25%
29%
increased
37%
41%
presses
21%
24%
skin problems
19%
22%
patient's condition
18%
21%